I-Mylasia evunyiweyo i-SARS-cov-2 antign yovavanyo lokuzivavanya

Imiyalelo yokusetyenziswa

-Ukusetyenziswa ekhaya

Ukuzivavanya okanye ukungabi nabungcali

-Ukusetyenziswa kwe-nasal cavity (i-natali engaphandle) yeSwab

-Kaloku-vitro Diactistik kuphela

Ukugcinwa

Ikhithi yovavanyo kufuneka igcinwe iziko le-2 ° C ~ 30 ~ 3 ° C, eyomileyo kunye nokukhanya kwelanga ngqo (sukuyikhulula ikhiti okanye izinto zayo).

Ubomi beshelup yekhithi yinyanga ezili-12.

Ikhadi lovavanyo kufuneka lisetyenziswe kwimizuzu engama-60 emva kokuvula ibhegi ye-aluminium foil.

Ngomhla wokuphelelwa kwekhitshi, nceda ujonge ileyibhile yemveliso.

Imvakalelo: 98.26% (95% CI 93.86% ~ 99.79%)

I-100,00% (i-95% ye-99.19% ~ 100.00%)

Ixabiso elifanelekileyo: I-100% (i-9% (95% CI 96.79% 100.00%)

Ixabiso eliqikelelweyo: 99.56% (95% CI 98.43% ~ 99.95%)

Isivumelwano sepesenti ngokubanzi: 99.65% (95% CI 98.74 ~ 99.96%)

Uvavanyo lwe-SARS-cov-2 antign luyenzelwe ukuphuculwa komgangatho we-SARS-2 antign kwi-Oropharysua Swab kunye ne-Nasopharyngezwa ye-vitro